Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This was the second lowest number of inspections per type of company made by the FDA in Arizona, equalling 4.9% of all inspections in the fourth quarter of 2023.
The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.
The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 4 | -- | -- |
| Blood and Blood Products | 5 | -- | -- |
| Compliance: Devices | 4 | 1 | -- |
| Drug Quality Assurance | -- | -- | 2 |
| Foodborne Biological Hazards | 21 | 1 | -- |
| Human Cellular, Tissue, and Gene Therapies | 1 | -- | -- |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 2 | -- | -- |
| Postmarket Assurance: Devices | 5 | -- | -- |
| Tobacco Post-Market Activities | 1 | -- | -- |
| Unapproved and Misbranded Drugs | -- | -- | 1 |
Alerts Sign-up